Viral hepatitis

Arie Regev, Eugene R. Schiff

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Viral hepatitis is still one of the most common causes of acute and chronic liver disease worldwide. Major advances have been made in our knowledge of these diseases, many during the past year. Molecular biology and clinical studies have improved our understanding of the mechanisms of antiviral drugs, as well as viral resistance to therapy. The risks of hepatitis A in patients with chronic liver disease have been confirmed, and the efficacy of hepatitis A vaccines in these patients has been proven. Aggressive combination therapy has emerged as a promising strategy for chronic hepatitis B and C, and techniques for immune prophylaxis for hepatitis B are being improved. Liver transplantation has become routine for end-stage hepatitis B virus liver disease, and new strategies to prevent and treat recurrence are being explored. This review discusses the recent advances in our knowledge of hepatitis viruses A through G, focusing on the literature of the past year.

Original languageEnglish (US)
Pages (from-to)234-239
Number of pages6
JournalCurrent opinion in gastroenterology
Issue number3
StatePublished - Jun 14 1999

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Viral hepatitis'. Together they form a unique fingerprint.

Cite this